U.S. markets closed
  • S&P 500

    -57.58 (-1.44%)
  • Dow 30

    -350.76 (-1.03%)
  • Nasdaq

    -225.05 (-2.00%)
  • Russell 2000

    -27.65 (-1.50%)
  • Crude Oil

    +0.40 (+0.54%)
  • Gold

    +1.00 (+0.06%)
  • Silver

    +0.02 (+0.09%)

    -0.0029 (-0.27%)
  • 10-Yr Bond

    -0.0860 (-2.39%)

    -0.0064 (-0.52%)

    +0.2120 (+0.16%)

    +54.16 (+0.32%)
  • CMC Crypto 200

    -1.32 (-0.33%)
  • FTSE 100

    -46.15 (-0.61%)
  • Nikkei 225

    +65.47 (+0.24%)

Erectile Dysfunction Drugs Market to Reach US$ 2.5 Bn by 2028, Says TMR Study

- Pharmaceutical companies in erectile dysfunction (ED) drugs market witnessing vast avenues in generic versions, underpinned by key drugs losing their patent

- Promotional and awareness campaigns along with patient education to spur revenue generation; North America highly lucrative market, fueled by high prevalence of ED

ALBANY, N.Y., April 14, 2022 /PRNewswire/ -- Pharmaceutical companies in the erectile dysfunction drugs market have reaped massive sales revenues on the back of widespread patient education about the treatment options for the condition. Over the past few decades, the utilization of oral phosphodiesterase type 5 inhibitors in ED drugs has propelled the revenue growth. The global valuation of the erectile dysfunction (ED) drugs market is projected to reach US$ 2.5 Bn by 2028.

TMR Logo
TMR Logo

Extensive use of cialis (tadalafil) and levitra/staxyn (vardenafil) in the patient population has spurred profitable opportunities in the erectile dysfunction (ED) drugs market. The demand for drug for the treatment of ED in elderly population has bolstered new revenue streams in recent years.

Extensive R&D by pharmaceutical and branded drugs manufacturers on pharmacological response test for erectile dysfunction are extending the horizon, finds TMR analysts in an in-depth report on the erectile dysfunction (ED) drugs market. Over the years, insurance coverage for the patient population has been reduced, thus impacting the growth opportunities for drug manufacturers.

Request Brochure of Erectile Dysfunction (ED) Drugs Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1550

Furthermore, a number of blockbuster patent expirations have gone off patent since the beginning of this decade. The trend has opened a new avenue for generic drug manufacturers, assert the authors of the study on the erectile dysfunction (ED) drugs market.

Key Findings of Erectile Dysfunction (ED) Drugs Market Study

  • Global Prevalence of ED Reinforces Treatment Innovations: The increasing prevalence of erectile dysfunction has propelled the adoption of medication drugs. The prevalence of the problem has increased on the back of the rapidly aging population in developing and developed economies. Pharmaceutical companies have been leveraging the synergistic abilities of mergers & acquisitions and research collaborations. This has nudged drug manufacturers to continue developing novel medications. Ongoing clinical trials will pave the way to innovative medications for ED.

  • Growing Product Approvals in Key Regions Invigorates Revenue Potential: Drug manufacturers are keen on improving the safety and efficacy of drugs in the newly launched medications. A proper understanding of psychological and organic causes of ED will enrich the revenue potential of the erectile dysfunction (ED) drugs market. In developed nations, notably the U.S., have in recent years witnessed approval of new drugs, and thus, has offered impetus to the expansion of the erectile dysfunction (ED) drugs market.

  • Loss of Patent Exclusivity of Branded Drugs to Turn Attention Toward Generics: In recent years, loss of patent exclusivity of key drugs in the erectile dysfunction (ED) drugs market has broadened the scope of commercialization of generic drugs in the erectile dysfunction (ED) drugs market. Major pharmaceutical companies are keen on tapping into the emerging revenue streams and increase their generic drug pipeline.

Request for Analysis of COVID-19 Impact on Erectile Dysfunction (ED) Drugs Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1550

Erectile Dysfunction (ED) Drugs Market: Key Drivers

  • Prevalence of ED in men above 40 years is a key driver of the erectile dysfunction (ED) drugs market. ED has been frequently associated with considerable emotional and psychological consequences on the quality of life of the patient. This has been driving the impetus for the various treatment options worldwide.

  • Growing awareness about the numerous risk factors of ED, such as hypertension, cardiovascular disease, diabetes mellitus, and hyperlipidemia will spur innovations in the erectile dysfunction (ED) drugs market

Erectile Dysfunction (ED) Drugs Market: Regional Growth Dynamics

  • North America held a major share of the global the erectile dysfunction (ED) drugs market in 2020. The U.S. and Canada have contributed sizable share of revenues to this regional market, propelled by widespread intake of ED drugs for treatment among the patient population.

  • Asia Pacific is another lucrative region in the global erectile dysfunction (ED) drugs market. Rise in patient education about the risk factors and awareness about the treatment options have reinforced the adoption of products.

Get Exclusive PDF Sample Copy of Erectile Dysfunction (ED) Drugs Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1550

Erectile Dysfunction (ED) Drugs Market: Key Players

Some of the key players in the erectile dysfunction (ED) drugs market are Teva Pharmaceutical Industries Ltd., Vivus, Inc., Bayer AG, Eli Lilly and Company, Dong-A ST Co., Ltd., and Pfizer, Inc.

Global Erectile Dysfunction (ED) Drugs Market: Segmentation

Erectile Dysfunction (ED) Drugs Market, by Drug

  • Viagra

  • Cialis

  • Staxyn/Levitra

  • Stendra/Spedra

  • Others

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1550

Erectile Dysfunction (ED) Drugs Market, by Distribution Channel

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

Erectile Dysfunction (ED) Drugs Market, by Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Erectile Dysfunction Shockwave Therapy Market: The global erectile dysfunction shockwave therapy market is driven by high prevalence and rise in incidence rate of erectile dysfunction across the globe. According to an independent survey, it is estimated that around 30 million men in the U.S. are affected by erectile dysfunction.

Erectile Dysfunction Treatment Devices Market: The global erectile dysfunction treatment devices market is projected to be primarily driven by the high prevalence and rising incidences of erectile dysfunction. Around 50% of men aged 40 to 70 years are estimated to suffer from some degree of erectile dysfunction.

Pelvic Floor Electrical Stimulation Devices Market: The market growth is primarily driven by the increasing prevalence of urinary incontinence among women worldwide, surge in the number of players manufacturing pelvic floor electrical stimulation devices, research and development activities, positive response from the FDA, and growing demand for pelvic floor electrical stimulation devices due to increase in public awareness and physiotherapist recommendations.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact :
Rohit Bhisey

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/erectile-dysfunction-drugs.htm


View original content:https://www.prnewswire.com/news-releases/erectile-dysfunction-drugs-market-to-reach-us-2-5-bn-by-2028--says-tmr-study-301525518.html

SOURCE Transparency Market Research